Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and an older funding/operating-status notice was removed; these are minor administrative updates that do not affect the study content or how you interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T13:59:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a government funding lapse notice about data currency and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the study record to display 'Last Update Submitted that Met QC Criteria' with revision v3.4.0. Removed the older label 'Last Update Submitted that met QC Criteria', adjusted capitalization of 'No FEAR Act Data' to 'No FEAR Act data', and updated the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:46.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision history updated: Revision v3.3.4 added and Revision v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:18:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a new Locations section with North Carolina as a study site. Removed the North Carolina Locations entry and the HHS Vulnerability Disclosure link; updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:15.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:39:44.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.